Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Current Medical Research and Opinion

Volumn 32, Issue 7, 2016, Pages 1243-1252

  Iglay, Kristy ^a   Hannachi, Hakima ^a   Howie, Patrick Joseph ^a   Xu, Jinfei ^a   Li, Xueying ^a   Engel, Samuel S ^a   Moore, Lori M ^a   Rajpathak, Swapnil ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Comorbidities; Hyperlipidemia; Hypertension; Multimorbidity; Obesity; Prevalence; Type 2 diabetes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DESCRIPTIVE RESEARCH; FEMALE; GENITAL CANDIDIASIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREATITIS; PREVALENCE; QUANTITATIVE ANALYSIS; RETINOPATHY; RETROSPECTIVE STUDY; SENESCENCE; SEX DIFFERENCE; URINARY TRACT INFECTION; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; HYPERLIPIDEMIAS; MIDDLE AGED; OVERWEIGHT;

AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84962045933     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2016.1168291     Document Type: Article

References (33)

1. D.Mozaffarian, E.J.Benjamin, A.S.Go, et al.; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics – 2016 Update: A report from the American Heart Association. Circulation 2016;133:e38-e360
2. R.A.Bailey, Y.Wang, V.Zhu, M.F.Rupnow Chronic kidney disease in US adults with type 2 diabetes: An updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes 2014;7:415
3. P.J.Lin, D.M.Kent, A.Winn,. Multiple chronic conditions in type 2 diabetes mellitus: Prevalence and consequences. Am J Manag Care 2015;21:e23-34
4. J.Piette, E.Kerr The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006;29:725-30
5. American Diabetes Association. Standards of medical care in diabetes – 2016. Diabetes Care 2016;39(Suppl 1):S1-S112
6. M.Monami, S.Genovese, E.Mannucci Cardiovascular safety of sulfonylureas: A meta-analysis of randomized clinical trials. Diabetes Obes Metab 2013;15:938-53
7. O.J.Phung, E.Schwartzman, R.W.Allen,. Sulphonylureas and risk of cardiovascular disease: Systematic review and meta-analysis. Diabet Med 2013;30:1160-71
8. B.M.Scirica, E.Braunwald, I.Raz,. Heart failure, saxagliptin, and diabetes mellitus: Observations from the SAVOR-TIMI 53 randomized trial. Circulation 2014;130:1579-88
9. W.B.White, C.P.Cannon, S.R.Heller, et al.; for the EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369:1327-35
10. J.B.Green, M.A.Bethel, P.W.Armstrong, et al.; for the TECOS Study Group. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;373:232-42
11. M.C.Salvo, A.D.Brooks, S.M.Thacker Patient considerations in the management of type 2 diabetes – critical appraisal of dapagliflozin. Patient Pref Adh 2014;8:493-502
12. B.Zinman, C.Wanner, J.Lachin,. Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes. N Engl J Med 2015;373:2117-28
13. A.A.Ginde, P.G.Blanc, R.M.Lieberman, C.A.CamargoJr.Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord 2008;8:4
14. C.Teljeur, S.M.Smith, G.Paul,. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract;19:17-22
15. G.E.Caughey, E.E.Roughead, A.I.Vitry,. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts 2010;87:385-93
16. E.Alonso-Morán, J.F.Orueta, J.I.Fraile Esteban,. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health 2014;14:1059
17. E.Selvin, C.M.Parrinello, D.B.Sacks, J.Coresh Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med 2014;160:517-25
18. J.Yoon, D.Zulman, J.Y.Scott, M.L.Maciejewski Costs associated with multimorbidity among VA patients. Med Care 2014;52(Suppl 3):S31-S6
19. M.Fortin, G.Bravo, C.Hudon,. Psychological distress and multimorbidity in primary care. Ann Fam Med 2006;4:417-22
20. M.Fortin, L.Lapointe, C.Hudon,. Multimorbidity and quality of life in primary care: A systematic review. Health Qual Life Outcomes 2004;2:51
21. J.M.Gunn, D.R.Ayton, K.Densley,. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol 2012;47:175-84
22. E.F.France, S.Wyke, J.M.Gunn,. Multimorbidity in primary care: A systematic review of prospective cohort studies. Br J Gen Pract 2012;62:e297-307
23. D.Grembowski, D.Paschane, P.Diehr,. Managed care, physician job satisfaction, and the quality of primary care. J Gen Intern Med 2005;20:271-7
24. D.C.Dugdale, R.Epstein, S.Z.Pantilat Time and the patient-physician relationship (Review). J Gen Intern Med 1999;14(Suppl 1):S34-S40
25. E.Wallace, C.Salisbury, B.Guthrie,. Managing patients with multimorbidity in primary care. BMJ 2015;350:h176
26. S.Stark Casagrande, J.E.Fradkin, S.H.Saydah,. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271-9
27. S.R.Pentakota, M.Rajan, B.G.Fincke,. Does diabetes care differ by type of chronic comorbidity? An evaluation of the Piette and Kerr framework. Diabetes Care 2012;35:1285-92
28. J.L.Wolff, B.Starfield, G.Anderson Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269-76
29. J.N.Struijs, C.A.Baan, F.G.Schellevis,. Comorbidity in patients with diabetes mellitus: Impact on medical health care utilization. BMC Health Serv Res 2006;6:84
30. U.Sambamoorthi, X.Tan, A.Deb Multiple chronic conditions and healthcare costs among adults. Expert Rev Pharmacoecon Outcomes Res 2015;15:823-32
31. X.Zhang, J.B.Saaddine, C.F.Chou,. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010;304:649-56
32. J.W.Yau, S.L.Rogers, R.Kawasaki,. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64
33. R.Klein, K.E.Lee, R.E.Gangnon, B.E.Klein The 25-year incidence of visual impairment in type 1 diabetes mellitus the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 2010;117:63-70